Cough syrup issue: Production halted at Maiden Pharmaceuticals

As reported by ET on Wednesday, a preliminary report revealed that several violations have been found at the facility. It said that in relation to the cough syrups, it has been found that the company has not done quality testing of propylene glycol for diethylene glycol and ethylene glycol.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/M1Nm2Jf
via IFTTT

0 comments:

Post a Comment